NASA Logo

NTRS

NTRS - NASA Technical Reports Server

Advisory – Planned Maintenance: On Monday, July 15 at 9 PM Eastern the STI Compliance and Distribution Services will be performing planned maintenance on the STI Repository (NTRS) for approximately one hour. During this time users will not be able to access the STI Repository (NTRS).

Back to Results
Association between Randall's Plaque and Calcifying NanoparticlesRandall initially described calcified subepithelial papillary plaques, which he hypothesized as nidi for kidney stone formation. The discovery of calcifying nanoparticles (CNP) in many calcifying processes of human tissues has raised another hypothesis about their possible involvement in urinary stone formation. This research is the first attempt to investigate the potential association of these two hypotheses. We collected renal papilla and blood samples from 17 human patients who had undergone laparoscopic nephrectomy due to neoplasia. Immunohistochemical staining (IHS) was applied on the tissue samples using monoclonal antibody 8D10 (mAb) against CNP. Homogenized papillary tissues and serum samples were cultured for CNP. Scanning electron microscopy (SEM) and energy dispersive X-ray spectroscopy (EDS) analysis were performed on fixed papillary samples. Randall's plaques were visible on gross inspection in 11 out of 17 collected samples. IHS was positive for CNP antigen in 8 of these 11 visually positive samples, but in only 1 of the remaining 6 samples. SEM revealed spherical apatite formations in 14 samples, all of which had calcium and phosphate peaks detected by EDS analysis. From this study, there was some evidence of a link between the presence of Randall's plaques and the detection of CNP, also referred to as nanobacteria. Although causality was not demonstrated, these results suggest that further studies with negative control samples should be made to explore the etiology of Randall's plaque formation, thus leading to a better understanding of the pathogenesis of stone formation.
Document ID
20070030847
Acquisition Source
Johnson Space Center
Document Type
Preprint (Draft being sent to journal)
Authors
Citfcioglu, Neva
(Nanobac Life Sciences Houston, TX, United States)
Vejdani, Kaveh
(California Univ. San Francisco, CA, United States)
Lee, Olivia
(California Univ. San Francisco, CA, United States)
Mathew, Grace
(Nanobac Life Sciences Houston, TX, United States)
Aho, Katja M.
(Kuopio Univ. Finland)
Kajander, Olavi
(Nanobac Pharmaceuticals Tampa, FL, United States)
McKay, David S.
(NASA Johnson Space Center Houston, TX, United States)
Jones, Jeffrey A.
(NASA Johnson Space Center Houston, TX, United States)
Feiveson, Alan H.
(NASA Johnson Space Center Houston, TX, United States)
Stoller, Marshall L.
(California Univ. San Francisco, CA, United States)
Date Acquired
August 24, 2013
Publication Date
January 1, 2007
Subject Category
Life Sciences (General)
Distribution Limits
Public
Copyright
Public Use Permitted.
No Preview Available